Similar articles for PMID: 18287266

Year	Number of Results
1981	1
1982	1
1983	5
1984	3
1985	6
1986	9
1987	11
1988	10
1989	12
1990	8
1991	11
1992	5
1993	7
1994	4
1995	6
1996	4
1997	8
1998	10
1999	9
2000	10
2001	13
2002	17
2003	15
2004	22
2005	16
2006	25
2007	16
2008	18
2009	17
2010	11
2011	22
2012	22
2013	14
2014	20
2015	14
2016	17
2017	21
2018	13
2019	10
2020	7
2021	9
2022	16
2023	11
2024	1

1

Quantitative measurements of bone remodeling using 99mTc-methylene diphosphonate bone scans and blood sampling.

Moore AE, Blake GM, Fogelman I. Moore AE, et al. J Nucl Med. 2008 Mar;49(3):375-82. doi: 10.2967/jnumed.107.048595. Epub 2008 Feb 20. J Nucl Med. 2008. PMID: 18287266 Free article.

2

Validation of a blood-sampling method for the measurement of 99mTc-methylene diphosphonate skeletal plasma clearance.

Moore AE, Blake GM, Fogelman I. Moore AE, et al. J Nucl Med. 2006 Apr;47(4):581-6. J Nucl Med. 2006. PMID: 16595490 Free article. Clinical Trial.

3

Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.

Blake GM, Park-Holohan SJ, Fogelman I. Blake GM, et al. J Nucl Med. 2002 Mar;43(3):338-45. J Nucl Med. 2002. PMID: 11884493 Free article.

4

Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.

Blake GM, Moore AE, Fogelman I. Blake GM, et al. Semin Nucl Med. 2009 Nov;39(6):369-79. doi: 10.1053/j.semnuclmed.2009.05.001. Semin Nucl Med. 2009. PMID: 19801217 Review.

5

Validation of ultrafiltration as a method of measuring free 99mTc-MDP.

Moore AE, Hain SF, Blake GM, Fogelman I. Moore AE, et al. J Nucl Med. 2003 Jun;44(6):891-7. J Nucl Med. 2003. PMID: 12791815 Free article. Clinical Trial.

6

A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.

Blake GM, Moore AE, Park-Holohan SJ, Fogelman I. Blake GM, et al. Nucl Med Commun. 2003 Jul;24(7):829-35. doi: 10.1097/00006231-200307000-00014. Nucl Med Commun. 2003. PMID: 12813203 Clinical Trial.

7

Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment.

Moore AE, Blake GM, Taylor KA, Rana AE, Wong M, Chen P, Fogelman I. Moore AE, et al. J Bone Miner Res. 2010 May;25(5):960-7. doi: 10.1359/jbmr.091108. J Bone Miner Res. 2010. PMID: 19929434 Free article. Clinical Trial.

8

Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.

Park-Holohan SJ, Blake GM, Fogelman I. Park-Holohan SJ, et al. Nucl Med Commun. 2001 Sep;22(9):1037-44. doi: 10.1097/00006231-200109000-00014. Nucl Med Commun. 2001. PMID: 11505214

9

Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?

Blake GM, Siddique M, Frost ML, Moore AE, Fogelman I. Blake GM, et al. Bone. 2011 Sep;49(3):537-42. doi: 10.1016/j.bone.2011.05.031. Epub 2011 Jun 13. Bone. 2011. PMID: 21689803

10

A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.

Moore AE, Blake GM, Fogelman I. Moore AE, et al. Nucl Med Commun. 2007 Mar;28(3):187-92. doi: 10.1097/MNM.0b013e3280143a0a. Nucl Med Commun. 2007. PMID: 17264777

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

472 results

Results by year